Cargando…
DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response
DNA intercalation is a major therapeutic modality for cancer therapeutic drugs. The therapeutic activity comes at a cost of normal tissue toxicity and genotoxicity. We have recently described a planar heterocyclic small molecule DNA intercalator, BMH-21, that binds ribosomal DNA and inhibits RNA pol...
Autores principales: | Colis, Laureen, Peltonen, Karita, Sirajuddin, Paul, Liu, Hester, Sanders, Sara, Ernst, Glen, Barrow, James C., Laiho, Marikki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147329/ https://www.ncbi.nlm.nih.gov/pubmed/24952786 |
Ejemplares similares
-
Design, Synthesis, and Structure–Activity
Relationships
of Pyridoquinazolinecarboxamides as RNA Polymerase I Inhibitors
por: Colis, Laureen, et al.
Publicado: (2014) -
The small-molecule BMH-21 directly inhibits transcription elongation and DNA occupancy of RNA polymerase I in vivo and in vitro
por: Jacobs, Ruth Q., et al.
Publicado: (2021) -
RNA Polymerase I Is Uniquely Vulnerable to the Small-Molecule Inhibitor BMH-21
por: Jacobs, Ruth Q., et al.
Publicado: (2022) -
Proteasome Activity Influences UV-Mediated Subnuclear Localization Changes of NPM
por: Moore, Henna M., et al.
Publicado: (2013) -
Identification of Novel p53 Pathway Activating Small-Molecule Compounds Reveals Unexpected Similarities with Known Therapeutic Agents
por: Peltonen, Karita, et al.
Publicado: (2010)